pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

Charicteristics of prescribed and non-prescribed group

Characteristicscholine alfoscerate n (%)aNon-choline alfoscerate n (%)p-valueb
 Total17,65556,756

Sex
 Male5,235 (29.7)14,600 (25.7)< 0.0001
 Female12,420 (70.4)42,156 (74.3)

Age
 0 ∼ 59476 (2.7)1,252 (2.2)
 60 ∼ 691,652 (9.4)4,799 (8.5)< 0.0001
 70 ∼ 797,064 (40.0)20,237 (35.7)
 80 ∼ 897,296 (41.3)25,142 (44.3)
 90 ≤1,167 (6.6)5,326 (9.4)

Type of Health Insurance
 Health Insurance14,770 (83.7)47,919 (84.4)0.0089
 Medical aid2,873 (16.3)8,818 (15.5)
 Government-subsidized medical care recipient12 (0.1)19 (0.03)

Medical Care Institution
 Tertiary hospital1,581 (9.0)5,232 (9.2)
 General hospital7,358 (41.7)19,604 (34.5)
 Hospital3,401 (19.3)8,794 (15.5)
 Nursing hospital472 (2.7)4,802 (8.5)< 0.0001
 Clinic4,665 (26.4)17,848 (31.5)
 Public health center42 (0.2)228 (0.4)
 Branch of Public Health Center1 (0.01)31 (0.1)
 Public Health & Medical Care Center135 (0.8)192 (0.3)
 Oriental Medicine Hospital-25 (0.04)

Medical Care Service
 Internal medicine1,963 (11.1)7,767 (13.7)
 Neurology8,823 (50.0)21,939 (38.7)
 Neuropsychiatry3,778 (21.4)17,095 (30.1)
 Surgery243 (1.4)1,005 (1.8)< 0.0001
 Orthopedic surgery66 (0.4)324 (0.6)
 Neurosurgery1,756 (10.0)3,363 (5.9)
 Rehabilitation medicine336 (1.9)870 (1.5)
 Family medicine499 (2.8)3,391 (6.0)
 Others191 (1.1)1,002 (1.8)

Region
 Seoul1,869 (10.6)7,613 (13.4)
 Busan1,540 (8.7)3,823 (6.7)
 Incheon669 (3.8)2,483 (4.4)
 Daegu1,124 (6.4)3,926 (6.9)
 Gwangju573 (3.3)2,051 (3.6)
 Daejeon542 (3.1)1,891 (3.3)
 Ulsan420 (2.4)727 (1.3)
 Gyeonggi3,627 (20.5)11,201 (19.7)< 0.0001
 Gangwon582 (3.3)1,974 (3.5)
 Chungbuk543 (3.1)1,671 (2.9)
 Chungnam757 (4.3)3,362 (5.9)
 Jeonbuk1,088 (6.2)3,742 (6.6)
 Jeonnam934 (5.3)3,087 (5.4)
 Gyeongbuk1,417 (8.0)3,933 (6.9)
 Gyeongnam1,848 (10.5)3,694 (6.5)
 Jeju122 (0.7)1,405 (2.5)
 Sejong-173 (0.3)

The proportion of each varable in the number of prescriptions

Chi - square test.

Korean J Clin Pharm 2019;29:1-8 https://doi.org/10.24304/kjcp.2019.29.1.1
© 2019 Korean J Clin Pharm